Ex parte A
17 USPQ2d 1716BPAI
AI-generated holding
A compound not specifically named in a reference is anticipated by a generic formula only if the classes of substituents are sufficiently limited or well delineated. Also, unexpected superior therapeutic activity against a class of bacteria can rebut prima facie obviousness even without evidence of effectiveness against all bacteria.
- Written by
- A language model, from how the MPEP uses this case rather than from the opinion.
- Confidence
- high — self-reported, not calibrated against a measured error rate
- Human review
- Not reviewed by a person
Read the opinion before relying on this in a filing. How these are made · Report an error